Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Mass Screening × Other solid neoplasm × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 6 Gynecologic 3 Breast 3 Other hematologic neoplasm 2 Head & Neck 2 Thoracic 1 Plasma cell 1 Other solid neoplasm 1 Myeloid 1 Lymphoid 1 Classical hematology 1

Conditions

Retinoblastoma 1

Interventions

Surveys and Questionnaires 6 Fluorodeoxyglucose F18 4 Magnetic Resonance Imaging 3 Blood Specimen Collection 3 larotrectinib 2 Watchful Waiting 2 Specimen Handling 2 Psychiatric Rehabilitation 2 Genetic Testing 2 Fluorouracil 2 Data Collection 2 Blood Component Removal 2 trifluridine tipiracil drug combination 1 tegafur-gimeracil-oteracil 1 etoposide phosphate 1 envafolimab 1 alovudine 1 Vascular Endothelial Growth Factor A 1 Tomography, Optical Coherence 1 Tomography, Emission-Computed 1 The Brief Resilience Scale 1 Tegafur 1 Syndecan-1 1 Spinal Cord Stimulation 1 S 1 (combination) 1 Radiomics 1 Radiofrequency Ablation 1 Proton Therapy 1 Postmortem Imaging 1 Positron-Emission Tomography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06367569 2024-04-16

TRbFU

Amsterdam UMC, location VUmc

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡